MENU
+Compare
PHGUF
Stock ticker: OTC
AS OF
Aug 11 closing price
Price
$1.16
Change
+$0.02 (+1.75%)
Capitalization
778.38M

PHGUF Pharming Group NV Forecast, Technical & Fundamental Analysis

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases... Show more

PHGUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PHGUF with price predictions
Aug 15, 2025

PHGUF's Stochastic Oscillator remains in overbought zone for 2 days

Expect a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

PHGUF broke above its upper Bollinger Band on August 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 11, 2025. You may want to consider a long position or call options on PHGUF as a result. In of 61 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PHGUF just turned positive on August 15, 2025. Looking at past instances where PHGUF's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PHGUF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.318) is normal, around the industry mean (19.433). P/E Ratio (0.000) is within average values for comparable stocks, (50.965). PHGUF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.945). Dividend Yield (0.000) settles around the average of (0.042) among similar stocks. P/S Ratio (2.610) is also within normal values, averaging (301.042).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PHGUF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PHGUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Darwinweg 24
Phone
+31 715247400
Employees
332
Web
https://www.pharming.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBRIX13.630.09
+0.66%
Neuberger Berman Real Estate I
EMEAX13.340.02
+0.15%
Ashmore Emerging Markets Equity A
GGEYX29.55-0.04
-0.14%
GuideStone Funds Growth Equity Instl
MFRLX50.57-0.14
-0.28%
MFS Research R1
FNKCX16.45-0.21
-1.26%
Frank Value C

PHGUF and Stocks

Correlation & Price change

A.I.dvisor tells us that PHGUF and DRUG have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHGUF and DRUG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHGUF
1D Price
Change %
PHGUF100%
N/A
DRUG - PHGUF
28%
Poorly correlated
-1.69%
CGTX - PHGUF
25%
Poorly correlated
-7.23%
IMMP - PHGUF
23%
Poorly correlated
+0.58%
XFOR - PHGUF
23%
Poorly correlated
-9.24%
TVGN - PHGUF
22%
Poorly correlated
-3.23%
More